{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:06:53Z","timestamp":1785434813211,"version":"3.56.0"},"reference-count":52,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013784","name":"Fu Jen Catholic University","doi-asserted-by":"publisher","award":["913M332-01"],"award-info":[{"award-number":["913M332-01"]}],"id":[{"id":"10.13039\/501100013784","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council","award":["111-2314-B-030-009"],"award-info":[{"award-number":["111-2314-B-030-009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glycine N-methyltransferase (GNMT), a S-adenosylmethionine (SAM)-dependent methyltransferase, is primarily expressed in the liver and plays a key role in regulating liver metabolism and protecting against liver injury. Several studies have shown that deficiency or downregulation of GNMT is strongly associated with the pathogenesis of hepatocellular carcinoma (HCC), highlighting its critical role as a tumor suppressor. Other studies have shown that GNMT is also strongly correlated with the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD). Although many factors regulate GNMT expression, recent studies have identified microRNAs (miRNAs), such as miR-873-5p and miR-224, as key post-transcriptional regulators that directly target GNMT mRNA and suppress its expression in HCC and MAFLD. This review provides an overview of GNMT\u2019s role in liver physiology and how its dysregulation contributes to the progression of HCC and MAFLD, with a focus on the regulation of GNMT by miR-873-5p and miR-224. We also highlight the potential of these two miRNAs as biomarkers and therapeutic targets for HCC and MAFLD, discussing emerging strategies such as antisense-based inhibition, gene therapy, and small-molecule inducers aimed at restoring GNMT expression.<\/jats:p>","DOI":"10.3390\/ijms27052090","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:54:56Z","timestamp":1771923296000},"page":"2090","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["GNMT and Its Regulatory MicroRNAs as Biomarkers and Therapeutic Targets for Metabolic Dysfunction-Associated Fatty Liver Disease and Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"27","author":[{"given":"Yung-Chi","family":"Lin","sequence":"first","affiliation":[{"name":"Graduate Institute of Biomedical and Pharmaceutical Science, College of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan"},{"name":"Molecular Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3182-3504","authenticated-orcid":false,"given":"Wei-You","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical and Pharmaceutical Science, College of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6374-6905","authenticated-orcid":false,"given":"Yi-Ming Arthur","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical and Pharmaceutical Science, College of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"28131","DOI":"10.1038\/s41598-024-77658-2","article-title":"Projected Epidemiological Trends and Burden of Liver Cancer by 2040 Based on GBD, CI5plus, and WHO Data","volume":"14","author":"Guo","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.32723","article-title":"International Trends in Hepatocellular Carcinoma Incidence, 1978\u20132012","volume":"147","author":"Petrick","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_3","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41598-025-91312-5","article-title":"Global Burden of MAFLD, MAFLD Related Cirrhosis and MASH Related Liver Cancer from 1990 to 2021","volume":"15","author":"Guo","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ramai, D., Tai, W., Rivera, M., Facciorusso, A., Tartaglia, N., Pacilli, M., Ambrosi, A., Cotsoglou, C., and Sacco, R. (2021). Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020184"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the Treatment of Non-Alcoholic Steatohepatitis","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","article-title":"Therapeutic Advances of MiRNAs: A Preclinical and Clinical Update","volume":"28","author":"Chakraborty","year":"2021","journal-title":"J. Adv. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of MiR-122 Expression in Liver Cancer Correlates with Suppression of the Hepatic Phenotype and Gain of Metastatic Properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"22507","DOI":"10.1074\/jbc.R109.019273","article-title":"Glycine N-Methyltransferase and Regulation of S-Adenosylmethionine Levels","volume":"284","author":"Luka","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_13","first-page":"1191","article-title":"Loss of the Glycine N-Methyltransferase Gene Leads to Steatosis and Hepatocellular Carcinoma in Mice","volume":"47","author":"Ariz","year":"2007","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ijc.23979","article-title":"Characterization of a Glycine N-Methyltransferase Gene Knockout Mouse Model for Hepatocellular Carcinoma: Implications of the Gender Disparity in Liver Cancer Susceptibility","volume":"124","author":"Liao","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_15","unstructured":"Chen, P.H. (2019). Characterization of MiR122\u2013GNMT Double Gene Knockout Mice and the Association Between Wound Healing and GNMT Deficiency. [Master\u2019s Thesis, Kaohsiung Medical University]."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep.21863","article-title":"Glycine N-methyltransferase\u2212\/\u2212 mice develop chronic hepatitis and glycogen storage disease in liver","volume":"46","author":"Liu","year":"2007","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1038\/s41598-018-30682-5","article-title":"MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma","volume":"8","author":"Hung","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41419-018-1014-y","article-title":"MiR-873-5p Acts as an Epigenetic Regulator in Early Stages of Liver Fibrosis and Cirrhosis","volume":"9","author":"Navasa","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1023\/A:1010577512912","article-title":"Glycine N-methyltransferase deficiency: A novel inborn error causing persistent isolated hypermethioninaemia","volume":"24","author":"Mudd","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1023\/B:BOLI.0000009978.17777.33","article-title":"Glycine N-methyltransferase deficiency: A new patient with a novel mutation","volume":"26","author":"Luka","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_21","first-page":"101","article-title":"Glycine N-Methyltransferase Deficiency: A Member of Dysmethylating Liver Disorders?","volume":"31","author":"Erdol","year":"2017","journal-title":"JIMD Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10545-016-9972-7","article-title":"Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders","volume":"40","author":"Staufner","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_23","unstructured":"Genetic and Rare Diseases Information Center (GARD) (2025, December 28). Glycine n-Methyltransferase Deficiency. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Available online: https:\/\/rarediseases.info.nih.gov\/diseases\/10764\/glycine-n-methyltransferase-deficiency."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO;2-2","article-title":"Characterization of Glycine-N-Methyltransferase-Gene Expression in Human Hepatocellular Carcinoma","volume":"75","author":"Chen","year":"1998","journal-title":"Int. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02256001","article-title":"Characterization of Reduced Expression of Glycine N-Methyltransferase in Cancerous Hepatic Tissues Using Two Newly Developed Monoclonal Antibodies","volume":"10","author":"Liu","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hep.23639","article-title":"Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide","volume":"52","author":"Embade","year":"2010","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2119\/molmed.2010.00243","article-title":"GNMT Expression Increases Hepatic Folate Contents and Folate-Dependent Methionine Synthase-Mediated Homocysteine Remethylation","volume":"17","author":"Wang","year":"2011","journal-title":"Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1158\/0008-5472.CAN-03-3726","article-title":"Glycine N-Methyltransferase tumor susceptibility gene in the Benzo(a)pyrene-detoxification pathway","volume":"64","author":"Chen","year":"2004","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.taap.2008.12.013","article-title":"Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect","volume":"235","author":"Yen","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1038\/s41598-018-22298-6","article-title":"Glycine N-methyltransferase inhibits aristolochic acid by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes","volume":"8","author":"Chang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/ijc.30652","article-title":"Characterization of the GNMT-HectH9-PREX2 Tripartite Relationship in the Pathogenesis of Hepatocellular Carcinoma","volume":"140","author":"Li","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11944","DOI":"10.1074\/jbc.RA118.002568","article-title":"Glycine N-Methyltransferase Deletion in Mice Diverts Carbon Flux from Gluconeogenesis to Pathways That Utilize Excess Methionine Cycle Intermediates","volume":"293","author":"Hughey","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2119\/molmed.2011.00258","article-title":"Glycine N-methyltransferase deficiency affects Niemann-Pick Type C2 protein stability and regulates hepatic cholesterol homeostasis","volume":"18","author":"Liao","year":"2012","journal-title":"Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101452","DOI":"10.1016\/j.molmet.2022.101452","article-title":"Disrupted Liver Oxidative Metabolism in Glycine N-Methyltransferase-Deficient Mice is Mitigated by Dietary Methionine Restriction","volume":"58","author":"Rome","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmet.2019.08.008","article-title":"MiR-873-5p Targets Mitochondrial GNMT-Complex II Interface Contributing to Non-Alcoholic Fatty Liver Disease","volume":"29","author":"Azkargorta","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0168-8278(00)80122-1","article-title":"Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma","volume":"33","author":"Avila","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1440-1746.2008.05488.x","article-title":"Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma","volume":"23","author":"Huang","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"24669","DOI":"10.1016\/S0021-9258(18)35816-2","article-title":"Purification and properties of pancreatic glycine N-methyltransferase","volume":"267","author":"Yeo","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_39","first-page":"21","article-title":"Epigenetic Silencing of GNMT Gene in Pancreatic Adenocarcinoma","volume":"12","author":"Botezatu","year":"2015","journal-title":"Cancer Genom. Proteom."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00432-017-2558-4","article-title":"Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: Implications for discovery of novel tumor-suppressor genes and therapeutic targets","volume":"144","author":"Goonesekere","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Heinzman, Z., Schmidt, C., Sliwinski, M.K., and Goonesekere, N.C.W. (2021). The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer. Pharmaceuticals, 14.","DOI":"10.3390\/ph14030209"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1158\/1078-0432.CCR-06-1551","article-title":"Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer","volume":"13","author":"Huang","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chen, M., Huang, Y.L., Huang, Y.C., Shui, I.M., Giovannucci, E., Chen, Y.C., and Chen, Y.M.A. (2014). Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the Health Professionals Follow-up Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094683"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e00070","DOI":"10.1042\/BSR20130030","article-title":"Androgen response element of the glycine N-methyltransferase gene is located in the coding region of its first exon","volume":"33","author":"Lee","year":"2013","journal-title":"Biosci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/JME-13-0169","article-title":"Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells","volume":"51","author":"Ottaviani","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2017.04.006","article-title":"c-Myc antagonises the transcriptional activity of the androgen receptor in prostate cancer affecting key gene networks","volume":"18","author":"Barfeld","year":"2017","journal-title":"eBioMedicine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41389-022-00382-x","article-title":"PI3K-regulated glycine N-methyltransferase is required for the development of prostate cancer","volume":"11","author":"Viera","year":"2022","journal-title":"Oncogenesis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.clinre.2015.11.005","article-title":"Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage","volume":"40","author":"Lin","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.3748\/wjg.v20.i41.15343","article-title":"Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies","volume":"20","author":"Lendvai","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kant, R., Yen, C.-H., Lu, C.-K., Lin, Y.-C., Li, J.-H., and Chen, Y.-M. (2016). Identification of 1,2,3,4,6-Penta-O-galloyl-\u03b2-D-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050669"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8992","DOI":"10.1021\/acs.jmedchem.1c00093","article-title":"Discovery of an Orally Efficacious MYC Inhibitor for Liver Cancer Using a GNMT-Based High-Throughput Screening System and Structure-Activity Relationship Analysis","volume":"64","author":"Kant","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/s41598-018-37292-1","article-title":"Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-\u03b2-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma","volume":"9","author":"Kant","year":"2019","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2090\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:21:23Z","timestamp":1772083283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27052090"],"URL":"https:\/\/doi.org\/10.3390\/ijms27052090","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}